Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet expects to beat revenue estimates on strong insulin pump demand
07:08am, Friday, 26'th Jul 2024
Insulet reported preliminary second-quarter revenue above Wall Street estimates on Friday, as it benefited from strong demand for its insulin delivery devices.
All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy
01:02pm, Thursday, 18'th Jul 2024
Insulet (PODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ESLOY vs. PODD: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 25'th Jun 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of EssilorLuxottica Unsponsored ADR (ESLOY) and Insulet (PODD). But which of these two stocks offers value
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
09:40am, Monday, 24'th Jun 2024
Insulet (PODD) reports positive findings from the SECURE-T2D pivotal trial, the largest study of AID therapy in people with type 2 diabetes.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today shared pos
Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System
09:36am, Friday, 21'st Jun 2024
Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
06:05am, Thursday, 20'th Jun 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
06:00am, Thursday, 20'th Jun 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made sever
The 3 Best Diabetes Stocks to Buy in June 2024
06:02am, Wednesday, 19'th Jun 2024
Since last October, there has been a marked reduction in fears about the sales of diabetes drugs dropping as a result weight-loss drugs. That's because Dexcom (NASDAQ: DXCM ) delivered stronger-than-e
Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?
10:33am, Thursday, 13'th Jun 2024
The robust performance of Insulet's (PODD) Omnipod 5 raises investors' optimism. However, concerns remain over the macroeconomic impacts and the company's overdependence on a single platform.
Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
04:27pm, Tuesday, 11'th Jun 2024
Insulet Corporation saw a significant drop in stock price in 2023 due to concerns over the impact of GLP-1 weight loss drugs on the insulin pump industry. These fears seem to be largely overblown, how
7 Stocks That Could Safely 10X by 2030
06:19am, Thursday, 06'th Jun 2024
There is no such thing as safe gains in the market, at least in the near term. However, many stocks are very solid and won't disappoint you in the long run.
Insulet to Present at the Jefferies Global Healthcare Conference
06:00am, Tuesday, 28'th May 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
Here's Why Insulet (PODD) is a Strong Momentum Stock
10:56am, Thursday, 23'rd May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 22'nd May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
